NR1D1 is located in the ERBB2 amplicon region of chromosome 17q12–21 and is thought to be part of the ERBB2 signature, which is associated with poor clinical outcome in breast cancer [8, 9]. The gene discussed is ERBB2; the disease is breast carcinoma.